Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Mechanisms of Striatal Neuronal Loss in Huntington’s Disease

FY 2014-15

Summary
Huntington's Disease (HD) is an autosomal dominant neurodegenerative motor and cognitive disorder affecting the striatum as a major target. Despite ubiquitous expression of mutant huntingtin protein (mhtt), the medium spiny (MSP) neurons of the striatum are a major target for neurodegeneration. The mechanism for preferred loss of MSPs is poorly understood. Limited autopsy findings in HD suggest degeneration may occur in sources of cortical and thalamic striatal afferents even prior to striatal neurons loss. The afferent neurotrophic hypothesis of HD suggests that striatal MSP loss results from impaired anterograde trophic support from massive excitatory afferents to the striatum. Previous work shows striatal afferents promote MSP survival, especially during development or in the face of degenerative stress. We hypothesize that pathology in major striatal afferents precedes striatal neuronal loss. Impaired anterograde trophic support may be a major mechanism for striatal degeneration in HD. This question is best addressed in an animal model. We will use the R6/2 mutant mouse, that develops characteristic hyperkinetic movements associated with striatal degeneration. We will determine whether sources of cortical and thalamic striatal afferents degenerate prior to the onset of MSP loss. We will identify neurons using immunohistochemical and histological markers, and quantify neuronal size and number in cortical and thalamic afferents during the R6/2 mouse lifespan using unbiased stereology. If our hypothesis is verified, this would indicate pathology in striatal afferents is a major contributor to striatal neuronal loss in HD, and suggest novel targets for focusing neuroprotective therapies beyond the striatum.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
331494
Name
Crevier-Sorbo Gabriel
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Mechanisms of Striatal Neuronal Loss in Huntington’s Disease
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bdnf; Huntington'S Disease; Movement Disorder; Neuroanatomy; Neurodegeneration; Parafascicular Nucleus; R6/2 Mouse Model; Stereology; Striatum; Substantia Nigra
Abstract
Huntington's Disease (HD) is an autosomal dominant neurodegenerative motor and cognitive disorder affecting the striatum as a major target. Despite ubiquitous expression of mutant huntingtin protein (mhtt), the medium spiny (MSP) neurons of the striatum are a major target for neurodegeneration. The mechanism for preferred loss of MSPs is poorly understood. Limited autopsy findings in HD suggest degeneration may occur in sources of cortical and thalamic striatal afferents even prior to striatal neurons loss. The afferent neurotrophic hypothesis of HD suggests that striatal MSP loss results from impaired anterograde trophic support from massive excitatory afferents to the striatum. Previous work shows striatal afferents promote MSP survival, especially during development or in the face of degenerative stress. We hypothesize that pathology in major striatal afferents precedes striatal neuronal loss. Impaired anterograde trophic support may be a major mechanism for striatal degeneration in HD. This question is best addressed in an animal model. We will use the R6/2 mutant mouse, that develops characteristic hyperkinetic movements associated with striatal degeneration. We will determine whether sources of cortical and thalamic striatal afferents degenerate prior to the onset of MSP loss. We will identify neurons using immunohistochemical and histological markers, and quantify neuronal size and number in cortical and thalamic afferents during the R6/2 mouse lifespan using unbiased stereology. If our hypothesis is verified, this would indicate pathology in striatal afferents is a major contributor to striatal neuronal loss in HD, and suggest novel targets for focusing neuroprotective therapies beyond the striatum.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Crevier-Sorbo, Gabriel
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~